Information Provided By: 
Fly News Breaks for January 5, 2017
EXAS
Jan 5, 2017 | 09:51 EDT
After Exact Sciences announced that the Blue Cross Blue Shield Association, or BCBSA, released a positive review of Cologuard, Craig-Hallum analyst Bill Bonello predicted the review should be a catalyst for increased coverage from the BCBSA companies and for other health plans who look to the BCBSA when making coverage decisions. Bonello, who thinks Cologuard coverage is "reaching a critical mass" where it will be difficult for other large insurers to not cover the test, reiterates his Buy rating and $26 price target on Exact Sciences.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
